可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Urbich C, Dimmeler S. Endothelial progenitor cells: characterizationand role in vascular biology[J]. Circ Res, 2004, 95(4):343-353.
[2] Zhou B, Cao XC, Fang ZH, et al. Prevention of diabetic microangiopathy by prophylactic transplant of mobilized peripheral blood mononuclear cells[J]. Acta Pharmacol Sin, 2007, 28(1):89-97.
[3] Zhou B, Ma FX, Liu PX, et al. Impaired therapeutic vasculogenesis by transplantation of OxLDL-treated endothelial progenitor cells[J]. J Lipid Res, 2007, 48(3):518-527.
[4] Yang C, Zhang ZH, Li ZJ, et al. Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation[J]. Thromb Haemost, 2004, 91(6):1202-1212.
[5] Li S, Zhou B, Han ZC. Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia: a comparison between CD34+ and CD34- mononuclear cells[J]. Thromb Haemost, 2006, 95(2):301-311.